Welcome Provider!
Blue Cross and Blue Shield of Illinois
   
gray line
Print Page
Fast Path
Home > Provider > HMO Prior Authorization and Step Therapy Programs
What's New
If you bill Medicare, read this! - New (May 2008)
Recall of Digitek
Provider Transparency Pilot Appeal Process
May Blue Review Available Now!
2008 Annual BCBSIL Hospital Profile
Availity Transition Updates
Avoid paper claim rejections! - New
Verification Needed With Provider Record Updates for NPI
Blue Medicare Private Fee-for-Service - New
Blue Distinction
THIN - Availity Migration

Updates
Updated Policy and Procedures
ICD-9-CM Billing Update
HMO Prior Authorization and Step Therapy Programs

As prescription drug costs continue to rise, employers, health plans and health care professionals are working together to find ways to manage medication use.

The HMO prior authorization (PA) and step therapy (ST) programs encourage the safe and cost-effective use of medication by allowing coverage when certain conditions are met. Blue Cross and Blue Shield of Illinois (BCBSIL) relies on a clinical team of physicians and pharmacists to identify, develop and approve the clinical programs and criteria for medications that are appropriate for prior authorization. The clinical team reviews FDA-approved labeling, scientific literature and nationally recognized guidelines.

The HMO PA and ST programs include management of the following medications:

Anabolic Steroids

  • Anadrol
  • Oxandrin
  • Winstrol

 

Growth Hormones

  • Genotropin
  • Humatrope
  • Norditropin
  • Nutropin/AQ
  • Saizen
  • Serostim

 

Hepatitis C

  • Copegus
  • Pegasys
  • Peg-Intron
  • Rebetol
  • Ribasphere
  • Ribavirin

 

Hypertension

ACE Inhibitors

  • Aceon
  • Accupril
  • Accuretic
  • Altace
  • Capoten
  • Capozide
  • Lotensin/HCT
  • Mavik
  • Monopril/HCT
  • Prinivil
  • Prinzide
  • Uniretic
  • Univasc
  • Vaseretic
  • Vasotec
  • Zestoretic
  • Zestril

ARBs

  • Atacand/HCT
  • Avalide
  • Avapro
  • Benicar/HCT
  • Cozaar
  • Diovan/HCT
  • Hyzaar
  • Micardis/HCT
  • Teveten/HCT

 

Insomnia Step Therapy:

  • Ambien
  • Ambien CR
  • Lunesta
  • Sonata
  • Rozerem

 

Oral Fentanyl Prior Authorization:

  • Actiq
  • Fentanyl lollipop
  • Fentora

 

Rheumatoid Arthritis/Psoriasis

  • Amevive
  • Enbrel
  • Humira
  • Kineret
  • Raptiva

 

When a member fills or refills a prescription for one of the medications listed above, the prescription claim will reject, and the pharmacy will receive a message stating that prior authorization is necessary. It will then be necessary for the physician to complete and submit a BCBSIL preauthorization request physician fax form. Continued use will be available if the patient's medical history and current medical condition warrant it.

For information about the prior authorization medical criteria for anabolic steroids and growth hormones, please review medical policies or the Rx clinical criteria.

If you have questions or concerns regarding these programs, please call the Pharmacy Program at (800) 423-1973.

ACE/ARB Fax Form (PDF, 35KB)
Amevive Fax Form (PDF, 37KB)
Anabolic Steroid Fax Form (PDF, 114KB)
Enbrel Fax Form (PDF, 37KB)
Growth Hormone Fax Form (PDF, 306KB)
Hepatitis C Fax Form (PDF, 40KB)
Humira Fax Form (PDF, 37KB)
Insomnia Agents Fax Form (PDF, 32KB)
Kineret Fax Form (PDF, 36KB)
Leukotriene Modifiers Fax Form (PDF, 29KB)
Oral Fentanyl Fax Form (PDF, 32KB)
Prior Authorization Program Member Brochure (PDF, 1.56MB)
Raptiva Fax Form (PDF, 36KB)
Step Therapy Program Member Brochure (PDF, 1.76MB)

 

A Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association.
© Copyright 2008. Health Care Service Corporation. All Rights Reserved.

Home | Important Information